# MVP-MOD-006-DEF Laboratory Workflow Capability Package Validation

Artifact ID: `HOP-QA-MVP-MOD-006-DEF-001`
Status: `passed`
Machine-readable source: `MVP-MOD-006-DEF-validation.md`

## Scope

- Backlog item: `MVP-MOD-006-DEF`
- Module: `MVP-MOD-006 Laboratory Workflow`
- Release: `REL-001`
- Execution flow stage: `model`
- Code implemented: **no** — this is a definition-only backlog item.

## Capabilities modeled

| Capability | Package folder | Bounded context | Aggregate role |
| --- | --- | --- | --- |
| BCM-LAB-002 Sample Collection | `bcm-lab-002-sample-collection/` | orders-samples | Owns AGG-008 Sample |
| BCM-LAB-003 Sample Labeling | `bcm-lab-003-sample-labeling/` | orders-samples | Delegated: `labelInfo` |
| BCM-LAB-005 Sample Reception | `bcm-lab-005-sample-reception/` | orders-samples | Delegated: `receptionRecord`, rejection-at-reception, disposal |
| BCM-LAB-006 Laboratory Processing | `bcm-lab-006-laboratory-processing/` | laboratory-results | Owns AGG-009 LaboratoryResult |
| BCM-LAB-008 Technical Validation | `bcm-lab-008-technical-validation/` | laboratory-results | Delegated: `technicalValidation`, `criticalFlag` |
| BCM-LAB-009 Medical Validation | `bcm-lab-009-medical-validation/` | laboratory-results | Delegated: `medicalValidation` |
| BCM-LAB-010 Result Release | `bcm-lab-010-result-release/` | laboratory-results | Delegated: `releaseRecord`, `amendments` |

Each package has the full 14-artifact set (13 YAML models + `README.md`), for 98 files total.

## Aggregate ownership design

Two aggregates are shared across sibling capabilities within the same bounded context, mirroring the
`DiagnosticOrder` / `BCM-LAB-001` ownership pattern already used in MVP-MOD-004:

- **Sample (AGG-008)**, bounded context `orders-samples`: owned by BCM-LAB-002, which models the full
  aggregate and creates it via `CollectSample`. BCM-LAB-003 and BCM-LAB-005 hold delegated authority
  over one named field each (`labelInfo`; `receptionRecord`/rejection-at-reception/disposal), each with
  an `architecture_boundary` rule restricting it to that field set.
- **LaboratoryResult (AGG-009)**, bounded context `laboratory-results`: owned by BCM-LAB-006, which
  models the full aggregate and creates it via `CaptureResultValue`. BCM-LAB-008, BCM-LAB-009 and
  BCM-LAB-010 hold delegated authority over their own named fields (`technicalValidation`/
  `criticalFlag`; `medicalValidation`; `releaseRecord`/`amendments`).

No capability outside these seven, and no other bounded context, may mutate either aggregate — this
matches `aggregate-catalog.md`'s `forbidden_mutators` declarations for AGG-008 and AGG-009.

## Clinical rules modeled (backlog minimum set)

| Requirement | Where modeled |
| --- | --- |
| Sample must reference a valid order | BCM-LAB-002 RN-001 |
| Traceable identification before reception/processing | BCM-LAB-002 RN-003, BCM-LAB-005 RN-001 |
| Audit on every transition | BCM-LAB-002 RN-004/RN-009, BCM-LAB-006 RN-007/RN-008 |
| Rejected sample must not be processed | BCM-LAB-002 RN-005, BCM-LAB-005 RN-002/RN-003 |
| Structured hemolysis/incidence reason | BCM-LAB-002 `SampleRejectionReason`, BCM-LAB-005 `ReceptionConditionCheck` |
| Result respects test/unit/range/method | BCM-LAB-006 RN-002/RN-003 |
| Validation by authorized role | BCM-LAB-008 RN-002, BCM-LAB-009 RN-002 |
| Critical result triggers notification hook | BCM-LAB-008 RN-003/RN-004 |
| Chain of custody preserved | BCM-LAB-002 `ChainOfCustodyEvent`, INV-COL-002/005 |
| No deletion of clinical evidence | BCM-LAB-002 RN-009, BCM-LAB-005 RN-004, BCM-LAB-010 RN-003 (append-only amendment) |

## Validations executed

19 validation checks (VAL-001 through VAL-019) covering artifact completeness, YAML syntax, BCM-001/
BCM-002/domain-foundation traceability, aggregate-ownership boundary compliance, business-rule format,
generation-plan separation, MDPE manual-authoring compliance, API/permission/UI/mobile surface
classification, agent-agnostic scanning, the clinical rule minimum set, HRP/BRM alignment, no
unauthorized aggregate duplication against MVP-MOD-002/003/004/005, and the AI-governance exclusion
for medical validation and release. All passed; zero blocking gaps.

## Technical debt

This backlog item made no code changes, so no code-changing debt item could be remediated directly.
The debt-first review requirement was still honored: `TD-BE-010` (order cancellation's downstream
sample-state check, explicitly deferred pending MVP-MOD-006 modeling) was identified as the one open
item this backlog's modeling work unblocks, and both `TD-BE-010-order-cancellation-sample-state-check-deferred.md`
and `technical-debt-index.md` were updated to record that its modeling precondition is now satisfied
— the code-level fix remains open, targeted at `MVP-MOD-006-BE-002`.

## Non-blocking observations

- Sample Transport (BCM-LAB-004) and Quality Control (BCM-LAB-007) remain MVP2-roadmap capabilities,
  explicitly out of scope.
- Mobile sample collection is modeled at intent level only (per the module's `sample_collection_later`
  declaration); no mobile screens are compiled by this or the next backend backlog item.

## Readiness

- `MVP-MOD-006-DEF` status: **closed**.
- HOP commercially complete: **no**. HOP GA-ready: **no**.
- Next backlog item: `MVP-MOD-006-BE-001` — Compile sample lifecycle backend outputs.
- Backend coverage 67.47%, frontend coverage 80.66% — both unchanged since no code was implemented in
  this backlog item.

<!-- NEXORA_STRUCTURED_PAYLOAD_V1 -->

## Structured Payload

```yaml
artifact:
  id: HOP-QA-MVP-MOD-006-DEF-001
  type: qa-validation-evidence
  name: MVP-MOD-006-DEF Laboratory Workflow Capability Package Validation
  version: 1.0.0
  status: passed
  human_readable: MVP-MOD-006-DEF-validation.md
  machine_readable: MVP-MOD-006-DEF-validation.md
  created_date: 2026-07-16
  owner: Nexora Product Architecture Team
scope:
  backlog_item: MVP-MOD-006-DEF
  module: MVP-MOD-006 Laboratory Workflow
  release: REL-001
  execution_flow_stage: model
  business_requirement_version: v0.68.0
  impact_assessment_required: false
  code_implemented: false
standards_validated_against:
- ../../../../nexora-framework/02-standards/standards/capability-package-standard.md
- ../../../../nexora-framework/02-standards/standards/model-driven-product-engineering-standard.md
- ../../../../nexora-framework/02-standards/standards/agent-agnostic-standard.md
- ../../../../nexora-framework/02-standards/standards/open-source-first-security-quality-standard.md
capabilities_validated:
- capability_id: BCM-LAB-002
  package_folder: 01-product-definition/business-capabilities/packages/bcm-lab-002-sample-collection/
  required_artifacts_present: true
  artifact_count: 14
  bounded_context: orders-samples
  primary_aggregate_reference: AGG-008 Sample (owner)
- capability_id: BCM-LAB-003
  package_folder: 01-product-definition/business-capabilities/packages/bcm-lab-003-sample-labeling/
  required_artifacts_present: true
  artifact_count: 14
  bounded_context: orders-samples
  primary_aggregate_reference: AGG-008 Sample (owned by BCM-LAB-002; labelInfo delegated)
- capability_id: BCM-LAB-005
  package_folder: 01-product-definition/business-capabilities/packages/bcm-lab-005-sample-reception/
  required_artifacts_present: true
  artifact_count: 14
  bounded_context: orders-samples
  primary_aggregate_reference: AGG-008 Sample (owned by BCM-LAB-002; receptionRecord/rejection/disposal
    delegated)
- capability_id: BCM-LAB-006
  package_folder: 01-product-definition/business-capabilities/packages/bcm-lab-006-laboratory-processing/
  required_artifacts_present: true
  artifact_count: 14
  bounded_context: laboratory-results
  primary_aggregate_reference: AGG-009 LaboratoryResult (owner)
- capability_id: BCM-LAB-008
  package_folder: 01-product-definition/business-capabilities/packages/bcm-lab-008-technical-validation/
  required_artifacts_present: true
  artifact_count: 14
  bounded_context: laboratory-results
  primary_aggregate_reference: AGG-009 LaboratoryResult (owned by BCM-LAB-006; technicalValidation/criticalFlag
    delegated)
- capability_id: BCM-LAB-009
  package_folder: 01-product-definition/business-capabilities/packages/bcm-lab-009-medical-validation/
  required_artifacts_present: true
  artifact_count: 14
  bounded_context: laboratory-results
  primary_aggregate_reference: AGG-009 LaboratoryResult (owned by BCM-LAB-006; medicalValidation
    delegated)
- capability_id: BCM-LAB-010
  package_folder: 01-product-definition/business-capabilities/packages/bcm-lab-010-result-release/
  required_artifacts_present: true
  artifact_count: 14
  bounded_context: laboratory-results
  primary_aggregate_reference: AGG-009 LaboratoryResult (owned by BCM-LAB-006; releaseRecord/amendments
    delegated)
validations:
- id: VAL-001
  name: Required artifact completeness
  method: Verify each package contains the 14 required capability package artifacts.
  result: passed
  detail: 7 packages x 14 artifacts = 98 artifacts present.
- id: VAL-002
  name: YAML syntax validation
  method: Parse all created and modified YAML files and fail on syntax errors.
  result: passed
  detail: All 91 new package YAML files (13 per package x 7 packages) plus updated
    capability-package-index.md, technical-debt-index.md, TD-BE-010-order-cancellation-sample-state-check-deferred.md,
    project and root PROJECT_STATE.md/SOURCE_OF_TRUTH.md and both commercial backlog/execution-prompt
    files parsed without errors.
- id: VAL-003
  name: Capability map traceability
  method: Confirm every package traces to a BCM-001 capability in DOM-05 with the
    exact canonical name.
  result: passed
  detail: BCM-LAB-002 Sample Collection, BCM-LAB-003 Sample Labeling, BCM-LAB-005
    Sample Reception, BCM-LAB-006 Laboratory Processing, BCM-LAB-008 Technical Validation,
    BCM-LAB-009 Medical Validation and BCM-LAB-010 Result Release all confirmed against
    01-product-definition/business-capabilities/bcm-001/business-capability-map.md
    with exact English/Spanish names; no invented names, no inconsistencies found.
- id: VAL-004
  name: Dependency map traceability
  method: Confirm every package declares the BCM-002 clinical_operations dependency
    profile and required/downstream capabilities.
  result: passed
  detail: All 7 packages declare dependency_profile clinical_operations, matching
    01-product-definition/business-capabilities/bcm-002/capability-dependency-map.md
    entries for BCM-LAB-002/003/005/006/008/009/010.
- id: VAL-005
  name: Domain foundation and aggregate-ownership traceability
  method: Confirm bounded context and aggregate ownership match the domain foundation,
    and that shared-aggregate ownership follows a single-owner-plus-delegated-mutators
    pattern.
  result: passed
  detail: AGG-008 Sample (bounded context orders-samples) is owned by BCM-LAB-002,
    which models the full aggregate; BCM-LAB-003 and BCM-LAB-005 each declare delegated
    authority over one named field set (labelInfo; receptionRecord/rejection-at-reception/disposal)
    and an architecture_boundary rule forbidding mutation of any other Sample field,
    mirroring aggregate-catalog.md's forbidden_mutators (laboratory-results, inventory-procurement,
    billing-tax excluded, not sibling orders-samples capabilities). AGG-009 LaboratoryResult
    (bounded context laboratory-results) is owned by BCM-LAB-006, which models the
    full aggregate; BCM-LAB-008, BCM-LAB-009 and BCM-LAB-010 each declare delegated
    authority over one named field set (technicalValidation/criticalFlag; medicalValidation;
    releaseRecord/amendments) with the same architecture_boundary pattern, mirroring
    aggregate-catalog.md's forbidden_mutators (orders-samples, billing-tax excluded).
    This mirrors the DiagnosticOrder/BCM-LAB-001 ownership pattern already validated
    in MVP-MOD-004-DEF.
- id: VAL-006
  name: Business rule format compliance
  method: Confirm rules follow RN-### format with required fields.
  result: passed
  detail: All rules include id, statement, applies_to, enforcement_point, severity,
    audit_required, test_refs.
- id: VAL-007
  name: Generation plan separation
  method: Confirm generation-plan separates generated outputs from custom implementation
    points.
  result: passed
  detail: Each of the 7 packages declares generated_outputs, custom_implementation_points
    and do_not_write_manually.
- id: VAL-008
  name: MDPE manual authoring compliance
  method: Confirm no CRUD, DTO, controller, repository, SDK, Swagger or repetitive
    tests were authored as implementation.
  result: passed
  detail: Repetitive artifacts declared as generated outputs only; no implementation
    code created during MVP-MOD-006-DEF.
- id: VAL-009
  name: API surface classification
  method: Confirm every openapi-source declares surface classification and per-operation
    generatable flags.
  result: passed
  detail: All operations classified internal; patient/doctor surfaces flagged status_later
    per module product_surfaces; BCM-LAB-002/006/010 note the module-level status_later
    boundary explicitly.
- id: VAL-010
  name: Permissions and audit coverage
  method: Confirm each package declares scopes, roles, access policies and audit obligations
    to BCM-PLT-007.
  result: passed
- id: VAL-011
  name: UI and mobile surface classification
  method: Confirm ui-model and mobile-model declare surface status per module product
    surfaces.
  result: passed
  detail: Employee portal required in all 7 packages; mobile_app sample_collection_later
    modeled with intended future flows in BCM-LAB-002 only (per module declaration),
    not_required elsewhere, with BCM-LAB-009 and BCM-LAB-010 explicitly deferring
    any future mobile surface to COM-MOD-009/MVP-MOD-007 respectively.
- id: VAL-012
  name: Registered path existence
  method: Confirm all package folders and index references resolve to existing files.
  result: passed
- id: VAL-013
  name: Agent-agnostic scan
  method: Scan created artifacts for named-agent, assistant, model-vendor or platform-runtime
    requirements.
  result: passed
  detail: No named-agent or vendor-runtime dependency found in package artifacts.
- id: VAL-014
  name: Cross-capability aggregate boundary compliance
  method: Verify that satellite capabilities (BCM-LAB-003/005/008/009/010) declare
    architecture_boundary rules restricting them to their own named field set, and
    that the owning capabilities (BCM-LAB-002/006) declare the reciprocal boundary.
  result: passed
  detail: BCM-LAB-002 RN-006, BCM-LAB-006 RN-006 declare that only the 3 (respectively
    4) named sibling capabilities may mutate the shared aggregate; BCM-LAB-003 RN-003,
    BCM-LAB-005 RN-005, BCM-LAB-008 RN-005, BCM-LAB-009 RN-004 and BCM-LAB-010 RN-005
    each declare the reciprocal restriction to their own field set.
- id: VAL-015
  name: Clinical rule minimum-set compliance
  method: Confirm the 10 clinical rules listed in the MVP-MOD-006-DEF backlog instructions
    are modeled somewhere in the 7 packages.
  result: passed
  detail: '(1) Sample-to-order association: BCM-LAB-002 RN-001. (2) Traceable identification
    before reception/processing: BCM-LAB-002 RN-003, BCM-LAB-005 RN-001. (3) Audit
    on every transition: BCM-LAB-002 RN-004/RN-009, BCM-LAB-006 RN-007/RN-008, all
    packages'' events audit:true. (4) Rejected sample must not be processed: BCM-LAB-002
    RN-005, BCM-LAB-005 RN-002/RN-003. (5) Structured incidence/hemolysis reason:
    BCM-LAB-002 VO-COL-006 SampleRejectionReason, BCM-LAB-005 VO-RCP-001 ReceptionConditionCheck.
    (6) Result capture respects test/unit/range/ method: BCM-LAB-006 RN-002/RN-003.
    (7) Validation by authorized role: BCM-LAB-008 RN-002, BCM-LAB-009 RN-002. (8)
    Critical result triggers notification hook: BCM-LAB-008 RN-003/RN-004. (9) Chain
    of custody preserved: BCM-LAB-002 VO-COL-007 ChainOfCustodyEvent, INV-COL-002/
    INV-COL-005. (10) No deletion of clinical evidence: BCM-LAB-002 RN-009, BCM-LAB-005
    RN-004, BCM-LAB-010 RN-003 (append-only amendment instead of in-place edit).'
- id: VAL-016
  name: HRP alignment
  method: Confirm alignment with HRP-001-P05 Sample Collection and Processing and
    HRP-001-P06 Result Validation and Release.
  result: passed
  detail: BCM-LAB-002/003/005/006 traceability.hrp_alignment declare their segment
    of P05; BCM-LAB-008/ 009/010 declare their segment of P06.
- id: VAL-017
  name: BRM alignment
  method: Confirm alignment with BRM-001 critical rules for sample traceability, rejected-sample
    blocking, critical-result notification, integration normalization, AI governance
    and audit.
  result: passed
  detail: BCM-LAB-002 aligns BRM-001-R009/R010/R018; BCM-LAB-005 aligns BRM-001-R009/R010/R018;
    BCM-LAB-006 aligns BRM-001-R010/R016/R017/R018; BCM-LAB-008 aligns BRM-001-R013/R017/R018;
    BCM-LAB-009 aligns BRM-001-R017/R018; BCM-LAB-010 aligns BRM-001-R010/R018.
- id: VAL-018
  name: No unauthorized aggregate duplication against dependent modules
  method: Confirm MVP-MOD-006 does not duplicate ownership of aggregates already owned
    by MVP-MOD-002/003/004/005 (TestDefinition, Patient, Doctor, DiagnosticOrder,
    Sale/Invoice) and instead references them by snapshot or read-only lookup.
  result: passed
  detail: BCM-LAB-002 references BCM-SVC-007's published SampleRequirement and the
    DiagnosticOrder's own PatientSnapshot (never BCM-PER-002 directly); BCM-LAB-006
    references BCM-SVC-004/006's published Analyte/ReferenceRange as immutable snapshots;
    BCM-LAB-009 references BCM-PER-003's doctor credential state read-only for licensed-authority
    verification. No package declares ownership of TestDefinition, Patient, Doctor,
    DiagnosticOrder, Sale or Invoice.
- id: VAL-019
  name: AI governance boundary compliance
  method: Confirm medical validation and release cannot be performed by an AI capability
    under any configuration.
  result: passed
  detail: BCM-LAB-009 RN-003 and BCM-LAB-010 POL-RLS-010-03 declare a hard architectural
    exclusion, aligned to BRM-001-R017 and context-map.md's FORBID-CTX-002.
blocking_gaps: []
non_blocking_observations:
- id: OBS-001
  description: TD-BE-010 (order cancellation's downstream sample-state check, deferred
    pending MVP-MOD-006 modeling) has its modeling precondition satisfied by this
    backlog item's Sample aggregate model; the code-level fix remains open, targeted
    at MVP-MOD-006-BE-002.
  disposition: tracked_in_technical_debt
  reference: 08-qa/technical-debt/TD-BE-010-order-cancellation-sample-state-check-deferred.md
- id: OBS-002
  description: Sample Transport (BCM-LAB-004) and Quality Control (BCM-LAB-007) are
    MVP2-roadmap capabilities explicitly out of scope for MVP-MOD-006; BCM-LAB-005
    models disposal as the terminal step instead of a transport handoff.
  disposition: tracked_as_documented_package_boundary
  reference: n/a (roadmap scope boundary, not a defect)
- id: OBS-003
  description: Mobile sample collection (BCM-LAB-002) is modeled at intent level only
    (mobile-model.md documents intended future flows) per the module's sample_collection_later
    product-surface declaration; no mobile screens are compiled by this or the next
    backend backlog item.
  disposition: tracked_as_documented_package_boundary
  reference: n/a (roadmap scope boundary, not a defect)
debt_first_review:
  applicable: true
  rationale: 'This is a definition-only backlog item with no code changes, so no code-changing
    debt item could be remediated. However, the technical-debt-index.md review requirement
    was still honored: TD-BE-010 was identified as the one open item directly unblocked
    by this backlog''s modeling work (its remediation_strategy explicitly named "gradual_when_mvp_mod_006_laboratory_workflow_is_modeled")
    and was updated accordingly (see OBS-001). No other open technical-debt item is
    modeling-, traceability-, YAML-, documentation-, agent-agnostic- or pointer-consistency-related
    in a way this backlog item could address.'
readiness:
  mvp_mod_006_def_status: closed
  ready_for_next_backlog_item: MVP-MOD-006-BE-001
  next_backlog_item_name: Compile sample lifecycle backend outputs
  hop_commercially_complete: false
  hop_ga_ready: false
  rationale: 'All seven Laboratory Workflow capability packages are modeled with the
    full required artifact set, traceable to BCM-001, BCM-002, domain foundation,
    business rules catalog, healthcare reference processes, permissions, events, APIs,
    UI, tests and observability, with generated versus custom implementation separated
    in generation plans. The Sample (AGG-008) and LaboratoryResult (AGG-009) shared-aggregate
    ownership pattern, all ten clinical rules from the backlog instructions, and the
    AI-governance exclusion for medical validation and release are modeled and verified.
    No blocking gaps remain; three non-blocking scope observations are tracked. No
    code was implemented in this backlog item; backend coverage remains 67.47% and
    frontend coverage remains 80.66%, both unchanged and not regressed. HOP is not
    commercially complete or GA-ready; MVP-MOD-006-BE-001 through MVP-MOD-006-CLOSEOUT,
    MVP-MOD-007 and MVP-MOD-008 remain planned within REL-001 alone.

    '
```
